The following are recommended at least yearly to monitor the efficacy of the oral thiamine therapy as well as disease progression:

Hematologic tests (CBC, reticulocyte count)

Hearing test

Assessment for glucose intolerance (fasting serum glucose concentration, OGTT, urinalysis)

Ophthalmologic evaluation

Cardiac evaluation

Neurologic evaluation
